Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biol Macromol ; 50(4): 957-64, 2012 May 01.
Article in English | MEDLINE | ID: mdl-22361455

ABSTRACT

Pleurotus eryngii, an edible mushroom with therapeutic potential was optimized using response surface methodology of four-factor Box-Behnken design for maximum mycelial biomass and extracellular glucan (EPS) production. The model predicts to gain a maximal mycelial biomass and extracellular polysaccharide at 39.4 g/l; 36.04 g/l of glucose, 8.27 g/l; 7.51 g/l of yeast extract, pH 6.99; 7.07 and temperature 26.2°C; 25.84°C, respectively. The validation experiments showed that the model was significant and in close agreement with the model prediction. The evaluation of extracellular polysaccharide on angiogenesis by ex vivo CAM assay showed that there was significant inhibition in neo-vascularization.


Subject(s)
Extracellular Space/metabolism , Glucans/biosynthesis , Glucans/pharmacology , Models, Statistical , Neovascularization, Pathologic/drug therapy , Pleurotus/cytology , Pleurotus/metabolism , Angiogenesis Inhibitors/biosynthesis , Angiogenesis Inhibitors/pharmacology , Angiogenesis Inhibitors/therapeutic use , Biomass , Chorioallantoic Membrane/blood supply , Chorioallantoic Membrane/drug effects , Fermentation , Glucans/therapeutic use , Mycelium/growth & development , Pleurotus/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...